Published 2018 | Version v1
Book Metadata-only

Clinical applications of lutetium based radiopharmaceuticals in molecular targeted therapy of cancer

Creators

  • 1. Radiation Medicine Centre, Tata Memorial Centre Annexe, Mumbai (India)

Description

Recent years have witnessed a major boost in molecular targeted therapy to metastatic/advanced malignancies with unsealed radiopharmaceuticals. In Indian centres at present. 177Lutetium based radiopharmaceuticals for receptor targeted therapy (177Lu-DOTATATE for Neuroendocrine tumors and 177Lu-PSMA for metastatic castrate resistant prostate cancer) constitute the centerpiece of this successful endeavor in clinical oncology practice. (author)

Part of:
Proceedings of the fourteenth DAE-BRNS biennial Trombay symposium on radiation and photochemistry

Additional details

Publishing Information

Publisher
Bhabha Atomic Research Centre
Imprint Place
Mumbai (India)
ISBN
81-88513-84-9
Imprint Title
Proceedings of the fourteenth DAE-BRNS biennial Trombay symposium on radiation and photochemistry
Imprint Pagination
174 p.
Journal Page Range
p. 27

Conference

Title
14. DAE-BRNS biennial Trombay symposium on radiation and photochemistry
Acronym
TSRP-2018
Dates
3-7 Jan 2018
Place
Mumbai (India)

INIS

Country of Publication
India
Country of Input or Organization
India
INIS RN
49055135
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
LUTETIUM 177; NEOPLASMS; PROSTATE; RADIATION DOSES; RADIOTHERAPY
Descriptors DEC
BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; DOSES; GLANDS; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LUTETIUM ISOTOPES; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; RARE EARTH NUCLEI; THERAPY

Optional Information